The Oncology Portfolio Acceleration (PA) team drives competitive advantage across the oncology commercial franchise by translating data, analytics, and strategic insights into measurable business outcomes. Sitting within Global Commercial Analytics and aligned closely with franchise and field leadership, the PA team accelerates portfolio performance and supports breakthrough decisions across the organization. The Director, Portfolio Acceleration – GU and Prostate Cancer serves as the primary partner to the CEP team, the Oncology Accounts Group (OAG), and the Oncology Account Marketing (OAM), transforming complex market dynamics, field force execution performance, and account-level intelligence into strategies that maximize franchise performance across the GU and Prostate Cancer portfolio, including Padcev, Xtandi, Talzenna, and Orgovyx, and other pipeline assets. The ideal candidate is an entrepreneurial, data-forward leader with oncology experience who operates at both the strategic and executional level. They bring a strong track record of building scalable analytics capabilities, influencing senior cross-functional stakeholders, and delivering insights with measurable business impact.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director